Scientists are exploring DNA-based robots, tiny molecular machines that could one day navigate the body, deliver targeted therapies, and even build nanoscale technologies.

Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced ...

Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...

By integrating machine learning models into the design process, researchers were able to predict how changes in protein structure would affect editing performance. This allowed them to systematically ...

A 7-week-old baby in Oregon is battling two rare conditions in a hospital pediatric intensive care unit nearly two months ...

Messenger RNA (mRNA) therapeutics have moved from a promising idea to clinical reality, accelerating vaccine development and ...

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

The field of plant biotechnology has quickly evolved with the advent of CRISPR-mediated gene editing, fundamentally transforming the exploration and ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Explore 40 years of PCR history, from Kary Mullis’s invention story to the rise of digital PCR and how it revolutionized ...

Funding will expand the range of Dualase® genome editors for new high morbidity and mortality genetic disease targets.

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...